| Date of Evaluation | Fertility (€) | Rel (%) | CI (days) | Survival (%) | Type of Proof |
|---|---|---|---|---|---|
| Sep 2025 | -26 | 87 | 2.27 | 0.41 | BLENDED GS |
| May 2025 | 25 | 87 | -0.24 | 1.75 | BLENDED GS |
| Date of Evaluation | Fertility (€) | Rel (%) | CI (days) | Survival (%) | Type of Proof |
|---|---|---|---|---|---|
| Sep 2025 | -26 | 87 | 2.27 | 0.41 | BLENDED GS |
| May 2025 | 25 | 87 | -0.24 | 1.75 | BLENDED GS |
| Number of IRL Daughters | Number of IRL Herds | Type of Proof |
|---|---|---|
| 415 | 144 | BLENDED GS |
| Date of Evaluation | Hrd | Dau | Herd Mates | Average CI | Average Survival | ||
|---|---|---|---|---|---|---|---|
| Dau | Herd Mates | Dau | Herd Mates | ||||
| Sep 2025 | 281 | 949 | 8126 | 384 | 383 | 84 | 85 |
| May 2025 | 259 | 828 | 6709 | 380 | 378 | 85 | 86 |
| Date of Evaluation | Hrd | Dau | Herd Mates | Average CI | Average Survival | ||
|---|---|---|---|---|---|---|---|
| Dau | Herd Mates | Dau | Herd Mates | ||||
| Sep 2025 | 281 | 949 | 8126 | 384 | 383 | 84 | 85 |
| May 2025 | 259 | 828 | 6709 | 380 | 378 | 85 | 86 |
| Parity 1-2 | Parity 2-3 | Parity 3-4 | Parity 4-5 | Parity 5-6 | |
|---|---|---|---|---|---|
| No. Daughters | 947 | 236 | |||
| No. Herds | 279 | 111 | |||
| No. without completed record | 484 | 637 | 237 |
| Parity 1-2 | Parity 2-3 | Parity 3-4 | Parity 4-5 | Parity 5-6 | |
|---|---|---|---|---|---|
| No. Daughters | 947 | 236 | |||
| No. Herds | 279 | 111 | |||
| No. without completed record | 484 | 637 | 237 |
| Number of IRL Daughters | Number of IRL Herds | Type of Proof |
|---|---|---|
| 415 | 144 | BLENDED GS |
| Country | Fertility | Survival | ||
|---|---|---|---|---|
| Daughters | Herds | Daughters | Herds | |
| AUS | 0 | 0 | 0 | 0 |
| CAN | 184 | 83 | 232 | 96 |
| DFS | 0 | 0 | 0 | 0 |
| FRA | 0 | 0 | 0 | 0 |
| GBR | 918 | 198 | 1000 | 200 |
| GER | 101 | 36 | 131 | 37 |
| ITA | 121 | 38 | 121 | 39 |
| NLD | 0 | 0 | 0 | 0 |
| NZL | 0 | 0 | 0 | 0 |
| USA | 0 | 0 | 1597 | 154 |